Lung Foundation New Zealand’s Position Statement and Advocacy Priorities are informed by evidence and based on a philosophy dedicated to saving lives. A schedule of lung cancer treatments by status is also included with this document. To view the document click here – 2018 Lung Foundation NZ – Position Statement & Schedule of Lung Cancer […]
Lung Cancer
TV One Sunday Q&A with Health Minister, David Clark
TVNZ’s Corin Dann interviews David Clark, Minister of Health on Sundays Q&A programme. https://www.tvnz.co.nz/shows/q-and-a/clips/q-a-david-clark-health-part-2 Lung Foundation NZ took the opportunity to put forward some questions on behalf of 2037 patients and their families who are currently dealing with a lung cancer diagnosis. 2018 April – Lung Foundation NZ – Q&A TV ONE – Minister of […]
Lung Foundation urges the Cancer Treatments Subcommittee to recommend Pharmac to reimburse Osimertinib (Tagrisso)
Osimertinib (Tagrisso) is currently being reviewed by the Cancer Treatments Subcommittee of PHARMAC (CaTSoP) to consider whether to fund Osimertinib to treat patients with EGFR T790 mutation positive non-small cell lung cancer (NSCLC). Lung Foundation New Zealand has written to CaTSoP on behalf of patients & families affected by lung cancer, urging this committee to […]
Bald Head Challenge in support of Lung Cancer
Big thanks to Cathy Zheng for her commitment to do a “Bald Head Challenge” by shaving her hair off on the 10th March to raise funds and awareness in support of our lung cancer programme. Cathy’s mother was diagnosed with lung cancer a couple of years ago and continues to do well with the […]
Meeting with Chair of the Health Select Committee
A productive meeting with Chair of the Health Select Committee & MP for Manurewa, Louisa Wall, which enabled Lung Foundation New Zealand to present our cause and highlight a number of the inequalities that exist for lung cancer. Louisa is well informed and we are most grateful she has agreed to take forward some of […]
Lung Cancer Patients waiting a year for Keytruda funding decision from Pharmac
Lung Foundation New Zealand continues to advocate for immunotherapy to be funded for lung cancer (a standard of care abroad). Meanwhile the very protracted process is costing lives. Story by: Amy Wiggins [email protected] New Zealand Herald 12 Feb, 2018 Hundreds of lung cancer patients whose lives could be saved by a new treatment labelled a […]
Lung Health Plenary confirmed for the 2019 General Practice Conference & Medical Exhibition (GPCME)
Lung Foundation New Zealand is very pleased to announce it has been given approval to plan and deliver a lung health plenary at the North and South General Practice Conference & Medical Exhibition (GPCME); – North GPCME, Rotorua, June 20-23rd 2019 – South GPCME, Christchurch, August 8-11th 2019 The GPCME is endorsed by The […]
Lung Cancer Patient, John Ashton, talks about Lung Cancer
To view Lung Cancer Patient Ambassador, John Ashton talking about his lung cancer journey, click the following link – https://m.youtube.com/watch?v=Ec3fk4OCau4
Recognising Simplot NZ and John West
It was very fitting to thank everyone at Simplot New Zealand and John West. Pictured below is; Chris Buddle, County Manager and Julian Ng, Group Brand Manager, together with colleagues at a presentation to acknowledge their tremendous support in conjunction with the John West 12k Traverse at the 2017 Auckland Marathon. These lung health champions […]
The Cost of Cancer
Lung cancer is NZ’s biggest cancer killer and it kills more people every year than Breast, Melanoma and Prostate Cancer combined. Lung Foundation New Zealand’s role is to advocate in support of patients and carers and urge policy makers to adopt policies that reduce/eliminate inequalities. This feature (see link below) highlights the many levels cancer […]